These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [The costs of Alzheimer's disease treatment: the rationale of acetylcholinesterase inhibitors use?]. Sobów TM; Kłoszewska I Psychiatr Pol; 1999; 33(5):761-7. PubMed ID: 10761441 [TBL] [Abstract][Full Text] [Related]
15. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease. Rabins PV; Lyketsos CG Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739 [No Abstract] [Full Text] [Related]
16. Adherence to cholinesterase inhibitors in patients with Alzheimer's disease. Blais L; Kettani FZ; Perreault S; Leroux JC; Forget A; Kergoat MJ J Am Geriatr Soc; 2009 Feb; 57(2):366-8. PubMed ID: 19207161 [No Abstract] [Full Text] [Related]
17. Alzheimer's disease: a tangled issue. Benson A Drug Discov Today; 2005 Jun; 10(11):749-51. PubMed ID: 15922931 [No Abstract] [Full Text] [Related]
18. Treatment of Alzheimer's disease. Mazurek AA N Engl J Med; 2000 Mar; 342(11):821; author reply 821-2. PubMed ID: 10722342 [No Abstract] [Full Text] [Related]
19. Drugs for Alzheimer's disease. Guidelines for prescribing cholinesterase inhibitors in Australia are similar to those in UK. Noble JM BMJ; 2001 Nov; 323(7321):1128. PubMed ID: 11725756 [No Abstract] [Full Text] [Related]
20. Currently used medicines for Alzheimer's disease are not very effective. Brenner S Am J Med; 2007 Dec; 120(12):e25; author reply e27. PubMed ID: 18060909 [No Abstract] [Full Text] [Related] [Next] [New Search]